Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 USD | +6.72% | +5.10% | -81.24% |
01:30pm | Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 20 | Tenax Therapeutics Secures Global Rights for Levosimendan | MT |
Chart calendar Tenax Therapeutics, Inc.
Upcoming events on Tenax Therapeutics, Inc.
No events available
Past events on Tenax Therapeutics, Inc.
2024-03-18 06:00 pm | ROTH Conference |
2024-03-06 09:39 am | Technology and Heart Failure Therapeutics Conference |
2024-01-02 | Reverse Split: 1 of 80 |
2023-11-29 | Extraordinary Shareholders Meeting |
2023-01-04 | Reverse Split: 1 of 20 |
2022-04-01 | American College of Cardiology Meeting |
2022-03-31 08:30 am | FY 2021 Earnings Release |
2022-01-04 | LifeSci Partners Corporate Access Event |
2021-11-16 08:30 am | Q3 2021 Earnings Release |
2021-09-29 01:35 pm | Benziga Healthcare Small Cap Conference |
2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
2021-08-17 08:00 am | Interim 2021 Earnings Release |
2021-08-16 10:00 am | Investor Meeting - Key Opinion Leader |
2021-06-09 | Annual General Meeting |
2021-05-17 05:15 pm | Q1 2021 Earnings Release |
2021-03-31 04:45 pm | FY 2020 Earnings Release |
2021-03-09 07:00 am | H.C. Wainwright Global Life Science Conference |
2021-01-21 04:30 pm | Acquisition of PH Precision Med by Tenax Therapeutics, Inc Management Discussion Call |
2020-11-18 04:30 pm | R&D Day |
2020-11-16 04:45 pm | Q3 2020 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -9,86 -8,90 -10.83% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,89 -6,95 0.82% | -8,56 -8,25 -3.7% | -9,87 -8,90 -10.88% | -32,7 -33,6 2.45% | -11,1 -12,0 7.92% | -7,39 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,81 -7,00 2.67% | -8,39 -8,40 0.07% | -9,85 -8,90 -10.69% | -32,5 -33,5 2.92% | -11,0 -12,0 7.96% | -7,18 |
Net income Million USD | Released Forecast Spread | -14,1 -6,85 -106.48% | -8,39 -11,9 29.16% | -9,85 -8,90 -10.69% | -32,5 -33,5 2.92% | -11,0 -12,0 7.96% | -7,18 |
EPS USD | Released Forecast Spread | -14 464 -6 648 -117.57% | -2 160 -2 488 13.18% | -2 128 -1 352 -57.4% | -2 528 -2 600 2.77% | -601 -745 19.33% | -28,8 |
Announcement Date | 01/04/19 | 30/03/20 | 31/03/21 | 29/03/22 | 31/03/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -3,80 -2,70 -40.83% | -3,21 -4,05 20.7% | -2,86 -2,50 -14.48% | -2,92 -3,25 10.23% | -2,55 -3,50 27.09% | -1,54 -2,63 41.53% | -1,24 -2,07 40.15% | -2,12 -2,60 18.56% | -2,49 | -2,86 | -2,48 | -2,75 | -2,94 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,80 -2,70 -40.69% | -3,21 -4,05 20.73% | -2,86 -2,50 -14.44% | -2,92 -3,25 10.26% | -2,55 -3,50 27.25% | -1,41 -2,63 46.57% | -1,11 -2,07 46.44% | -1,97 -2,60 24.15% | -2,49 | -2,86 | -2,48 | -2,75 | -2,94 | |
Net income Million USD | Released Forecast Spread | -3,80 -2,70 -40.69% | -3,21 -4,05 20.73% | -2,72 | -2,86 -2,50 -14.44% | -2,92 -3,25 10.26% | -2,55 -3,50 27.25% | -1,41 -2,63 46.57% | -1,11 -2,07 46.44% | -1,97 -2,60 24.15% | -2,49 | -2,86 | -2,48 | -2,75 | -2,94 |
EPS USD | Released Forecast Spread | -240 -208 -15.38% | -64,0 -256 75% | -176 | -176 -144 -22.22% | -176 -168 -4.76% | -72,8 -212 65.73% | -12,0 -29,6 59.46% | -4,00 -8,00 50% | -6,40 -9,60 33.33% | -8,15 | -1,86 | -1,26 | -1,34 | -1,10 |
Announcement Date | 15/11/21 | 29/03/22 | 16/05/22 | 11/08/22 | 10/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | - | - | - | - | - |
Past sector events for Tenax Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Tenax Therapeutics, Inc. - Nasdaq
- Calendar Tenax Therapeutics, Inc.